Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing: Letter to Health Care Providers | NLM

Disaster Information Management Research Center | NLM

Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing: Letter to Health Care Providers

10/07/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 10/7/2020. The U.S. Food and Drug Administration (FDA) provides these recommendations that health care providers give clear, step-by-step instructions to patients who, in a health care setting, are self-collecting anterior nares (nasal) samples for SARS-CoV-2 testing. Without proper instructions, patients may not collect an adequate sample for testing, which may decrease the sensitivity of the test. (Text)